Los puntos clave no están disponibles para este artículo en este momento.
Cardiac myocytes undergo programmed cell death as a result of ischemia/reperfusion (I/R). One feature of I/R injury is the increased presence of autophagosomes. However, to date it is not known whether macroautophagy functions as a protective pathway, contributes to programmed cell death, or is an irrelevant event during cardiac I/R injury. We employed simulated I/R of cardiac HL-1 cells as an in vitro model of I/R injury to the heart. To assess macroautophagy, we quantified autophagosome generation and degradation (autophagic flux), as determined by steady-state levels of autophagosomes in relation to lysosomal inhibitor-mediated accumulation of autophagosomes. We found that I/R impaired both formation and downstream lysosomal degradation of autophagosomes. Overexpression of Beclin1 enhanced autophagic flux following I/R and significantly reduced activation of pro-apoptotic Bax, whereas RNA interference knockdown of Beclin1 increased Bax activation. Bcl-2 and Bcl-xL were protective against I/R injury, and expression of a Beclin1 Bcl-2/-xL binding domain mutant resulted in decreased autophagic flux and did not protect against I/R injury. Overexpression of Atg5, a component of the autophagosomal machinery downstream of Beclin1, did not affect cellular injury, whereas expression of a dominant negative mutant of Atg5 increased cellular injury. These results demonstrate that autophagic flux is impaired at the level of both induction and degradation and that enhancing autophagy constitutes a powerful and previously uncharacterized protective mechanism against I/R injury to the heart cell. Cardiac myocytes undergo programmed cell death as a result of ischemia/reperfusion (I/R). One feature of I/R injury is the increased presence of autophagosomes. However, to date it is not known whether macroautophagy functions as a protective pathway, contributes to programmed cell death, or is an irrelevant event during cardiac I/R injury. We employed simulated I/R of cardiac HL-1 cells as an in vitro model of I/R injury to the heart. To assess macroautophagy, we quantified autophagosome generation and degradation (autophagic flux), as determined by steady-state levels of autophagosomes in relation to lysosomal inhibitor-mediated accumulation of autophagosomes. We found that I/R impaired both formation and downstream lysosomal degradation of autophagosomes. Overexpression of Beclin1 enhanced autophagic flux following I/R and significantly reduced activation of pro-apoptotic Bax, whereas RNA interference knockdown of Beclin1 increased Bax activation. Bcl-2 and Bcl-xL were protective against I/R injury, and expression of a Beclin1 Bcl-2/-xL binding domain mutant resulted in decreased autophagic flux and did not protect against I/R injury. Overexpression of Atg5, a component of the autophagosomal machinery downstream of Beclin1, did not affect cellular injury, whereas expression of a dominant negative mutant of Atg5 increased cellular injury. These results demonstrate that autophagic flux is impaired at the level of both induction and degradation and that enhancing autophagy constitutes a powerful and previously uncharacterized protective mechanism against I/R injury to the heart cell. Autophagy involves processes for the turnover of long lived macromolecules and organelles via the lysosomal degradative pathway (1Klionsky D.J. Emr S.D. Science. 2000; 290: 1717-1721Crossref PubMed Scopus (2988) Google Scholar, 2Cuervo A.M. Mol. Cell. Biochem. 2004; 263: 55-72Crossref PubMed Scopus (395) Google Scholar). Macroautophagy (referred to hereafter as autophagy) is a specific mode of autophagy in which isolation membranes envelop a portion of the cytosol, containing nonspecific cytosolic components, selectively targeted toxic protein aggregates (3Ravikumar B. Vacher C. Berger Z. Davies J.E. Luo S. Oroz L.G. Scaravilli F. Easton D.F. Duden R. O'Kane C.J. Rubinsztein D.C. Nat. Genet. 2004; 36: 585-595Crossref PubMed Scopus (1990) Google Scholar), intracellular pathogens (4Gutierrez M.G. Master S.S. Singh S.B. Taylor G.A. Colombo M.I. Deretic V. Cell. 2004; 119: 753-766Abstract Full Text Full Text PDF PubMed Scopus (1769) Google Scholar), or organelles such as mitochondria (5Xue L. Fletcher G.C. Tolkovsky A.M. Curr. Biol. 2001; 11: 361-365Abstract Full Text Full Text PDF PubMed Scopus (214) Google Scholar, 6Priault M. Salin B. Schaeffer J. Vallette F.M. di Rago J.P. Martinou J.C. Cell Death Differ. 2005; 12: 1613-1621Crossref PubMed Scopus (242) Google Scholar). The autophagosomes are then delivered to the lysosome, forming the autophagolysosome, for subsequent degradation of their contents by lysosomal hydrolases (Fig. 10). Interest in autophagy has increased recently, because of the recognition of its involvement in caspase-independent programmed cell death (PCD 2The abbreviations used are: PCD, programmed cell death; AVs, autophagic vacuoles; GFP, green fluorescent protein; KH, Krebs-Henseleit; 3-MA, 3-methyladenine; PI3K, phosphatidylinositol 3-kinase; I/R, ischemia/reperfusion; sI/R, simulated ischemia/reperfusion; RNAi, RNA interference; PI3P, phosphatidylinositol 3-phosphate; mTOR, mammalian target of rapamycin; ER, endoplasmic reticulum. type II) and its regulation by components of the apoptotic death pathway (PCD type I) (7Saeki K. Yuo A. Okuma E. Yazaki Y. Susin S.A. Kroemer G. Takaku F. Cell Death Differ. 2000; 7: 1263-1269Crossref PubMed Scopus (172) Google Scholar, 8Yanagisawa H. Miyashita T. Nakano Y. Yamamoto D. Cell Death Differ. 2003; 10: 798-807Crossref PubMed Scopus (91) Google Scholar, 9Shimizu S. Kanaseki T. Mizushima N. Mizuta T. Arakawa-Kobayashi S. Thompson C.B. Tsujimoto Y. Nat. Cell Biol. 2004; 6: 1221-1228Crossref PubMed Scopus (1192) Google Scholar). Anti-apoptotic Bcl-2 and Bcl-xL have been linked to the autophagic pathway via an interaction with Beclin1, a key mediator of autophagic activity (9Shimizu S. Kanaseki T. Mizushima N. Mizuta T. Arakawa-Kobayashi S. Thompson C.B. Tsujimoto Y. Nat. Cell Biol. 2004; 6: 1221-1228Crossref PubMed Scopus (1192) Google Scholar, 10Liang X.H. Kleeman L.K. Jiang H.H. Gordon G. Goldman J.E. Berry G. Herman B. Levine B. J. Virol. 1998; 72: 8586-8596Crossref PubMed Google Scholar). Autophagy is a vital process in the heart, presumably participating in the removal of dysfunctional cytosolic components and serving as a catabolic energy source during times of starvation. For example, autophagy in cardiac myocytes has been suggested to provide a necessary source of energy between birth and suckling (11Kuma A. Hatano M. Matsui M. Yamamoto A. Nakaya H. Yoshimori T. Ohsumi Y. Tokuhisa T. Mizushima N. Nature. 2004; 432: 1032-1036Crossref PubMed Scopus (2405) Google Scholar), and in a GFP-LC3 transgenic mouse, cardiac myocytes from starved animals displayed high numbers of autophagosomes, some of which contained mitochondria (12Mizushima N. Yamamoto A. Matsui M. Yoshimori T. Ohsumi Y. Mol. Biol. Cell. 2004; 15: 1101-1111Crossref PubMed Scopus (1942) Google Scholar). On the other hand, impaired autophagy a in cardiac autophagic removal of mitochondria the source of a toxic that during the A. J. Biochem. PubMed Scopus Google Scholar), and of the results in reduced Y. R. K. Mol. 2001; 7: Full Text Full Text PDF PubMed Scopus Google Scholar). of the autophagic pathway to cardiac cell death lysosomal is and lysosomal are the K. J. Google Scholar). the we the and regulation of autophagy during ischemia/reperfusion injury. a of of in and in to However, that cell or to cell death Autophagy a protective to I/R injury, as increased of autophagosomes has been in to in the heart K. J. Google Scholar). it that increased Beclin1 expression in the heart with the of in an in model of L. H. M. G. Matsui Y. J. S. A. 2005; PubMed Scopus Google Scholar). The cardiac HL-1 cell to simulated I/R as an in vitro model of I/R injury to the heart. high we the autophagic to results that in HL-1 cardiac myocytes to sI/R, autophagic flux is impaired at the level of both induction and a vital protective against injury. autophagic of the cardiac is protective against injury. and were from Cell and of the cardiac cell HL-1 A. S. A. 1998; PubMed Scopus Google were in and in with and B. were with the the or to the at and RNA with to the of Beclin1 were the a that a RNA a RNA which is then by the machinery M. D. 2005; PubMed Scopus Google Scholar). The target and to other as determined by The used to which were the which has expression of for of by The and were and cells were with both to To for nonspecific the used as a were in and by a to and the in with of by a to in and at in were in for for of that with of the cell not were a with a a and a and a a and and by a by an for and via a and an for and were from were of a to are of with cellular of and are known to by the Y. Mizushima N. Yamamoto A. S. Ohsumi Y. Yoshimori T. J. Cell 2004; PubMed Scopus Google Scholar). in of in HL-1 cells not cellular contents of autophagosomal were quantified via of GFP-LC3 Y. Mizushima N. T. Yamamoto A. T. T. E. Ohsumi Y. Yoshimori T. J. 2000; PubMed Scopus Google or To from the Nat. 2004; PubMed Scopus Google and with enhanced of the Y. Mizushima N. T. Yamamoto A. T. T. E. Ohsumi Y. Yoshimori T. J. 2000; PubMed Scopus Google HL-1 cells were with and cells were to as were with in for To the autophagic in a of cells were at and as or as autophagic cells were in of or For of the autophagic of of of cells in were the with the of the cell. were and and of the autophagosome cell were determined of autophagic cells were to the with and a of the lysosomal to A. Y. Yoshimori T. Y. R. Y. Cell 1998; PubMed Scopus Google Scholar), of and to lysosomal of GFP-LC3 used to cellular autophagosomal as of the is a that selectively with and used to C. J. B. Mol. Biol. Cell. 2000; 11: PubMed Scopus Google Scholar). and cells were with for in the then with and cells were by and intracellular of a lysosomal were to the cells during the of an to the of A. J. Cell Biol. PubMed Scopus Google or A. PubMed Scopus Google used as a to cellular injury. were with and the and to for were then to of in by of and cells were by were as cells with or cells were at in of were by and at for at and with To cell cell were in and and for The cell were at for to cellular of and were at for and to membranes against Bcl-2 Bcl-xL Beclin1 and fluorescent protein to and and and were because of in and to the that are used against are of at of between determined by the are as of at Cell Death in HL-1 Cardiac HL-1 cell is an model for of cardiac cell J. 2004; PubMed Scopus Google Scholar). HL-1 cells in to simulated I/R via in cardiac I/R injury A. PubMed Scopus Google Scholar). One key feature of cell death is the of the pro-apoptotic Bcl-2 protein Bax in the death Bax a in the pathway, is by a from the to at the mitochondria and quantified via fluorescent of a protein (Fig. A. J. Cell Biol. PubMed Scopus Google Scholar). as an to activation of PCD, we found that in a (Fig. Overexpression of both Bcl-2 and known against cardiac I/R injury V. A. M. M. M. A. H. J. 2000; PubMed Scopus Google Scholar, J. K. Y. T. M. S. K. T. Y. K. K. H. 2005; PubMed Scopus Google Scholar, K. C. E. 2004; PubMed Scopus Google Scholar), significantly reduced of the model (Fig. and during the of used HL-1 cells to the of autophagy during injury. To whether autophagic activity is in to sI/R, we in cellular autophagosomal high of the of cytosolic is and to Y. Mizushima N. Yamamoto A. S. Ohsumi Y. Yoshimori T. J. Cell 2004; PubMed Scopus Google Scholar, N. T. E. 2005; PubMed Scopus Google Scholar). is then to the autophagosomal N. Yamamoto A. Hatano M. Y. Y. K. Tokuhisa T. Ohsumi Y. Yoshimori T. J. Cell Biol. 2001; PubMed Scopus Google Scholar). autophagosomes, to as autophagic of not affect autophagic and transgenic GFP-LC3 (12Mizushima N. Yamamoto A. Matsui M. Yoshimori T. Ohsumi Y. Mol. Biol. Cell. 2004; 15: 1101-1111Crossref PubMed Scopus (1942) Google Scholar, T. M. N. K. Ohsumi M. Yoshimori T. T. Ohsumi Y. J. Cell Biol. PubMed Scopus Google Scholar). We HL-1 cardiac myocytes with GFP-LC3 and the of in cells to to in GFP-LC3 the with (Fig. to sI/R, displayed increased numbers of (Fig. in cells the were whereas in cells to were at the of the cell. with the autophagic to in such R. S.A. 7: PubMed Scopus Google Scholar). To the in AVs, the of cells GFP-LC3 a of cells displayed GFP-LC3 in or (Fig. cells to sI/R, the of cells with significantly increased (Fig. of GFP-LC3 that significantly increased the of cell the autophagosomal (Fig. in during and results demonstrate that cellular increased in the We the of autophagic Autophagy involves the of the autophagosomes and their contents to that the degradative to the catabolic processes of autophagy (1Klionsky D.J. Emr S.D. Science. 2000; 290: 1717-1721Crossref PubMed Scopus (2988) Google Scholar). the increased presence of enhanced formation of AVs, impaired of with to or a of the by lysosomal degradation at a that the is the that a at a of to or high autophagic To autophagic we determined of the of degradation and downstream lysosomal of during an the of downstream lysosomal degradation of and their we determined whether the in cellular during of increased or impaired were to and with a of lysosomal to formation and lysosomal activity and the lysosomal inhibitor-mediated in accumulation a cell we were to a of the flux of formation and with the of cells high levels in the and presence of lysosomal The between the in is a of the of cells high autophagic or We found that in increased in the presence of (Fig. and in which the and component of autophagy is the of GFP-LC3 (Fig. autophagic activity in the of cells with increased numbers of (Fig. lysosomal the of cells with high increased that the previously in cellular in (Fig. and is a of an accumulation of AVs, presumably to in the autophagic pathway at a following formation and the level of accumulation the inhibitor-mediated in for the of it that autophagy is impaired at the level of were during the as cells the were of AVs, with or lysosomal a of autophagy during the (Fig. a necessary component of the as cells in a of autophagic which (Fig. during for the accumulation of during a lysosomal To lysosomal HL-1 cells were in which the lysosomal and activity of the and sI/R, we of with its in cell during I/R E. 1998; PubMed Scopus Google Scholar), activity of the is during the (Fig. we determined the activity and of a lysosomal a that by M. B. T. J. 2005; Google Scholar). We did not a in activity following sI/R, as and displayed an with the (Fig. we found that activity not in the cytosol, that is not from the following results a lysosomal during the of Autophagy in results demonstrate that formation of is during and that autophagic flux during to whether autophagy a protective or a component of injury, we the autophagic pathway and at the levels of induction formation of of Autophagy the autophagic pathway, with and autophagy A. E. J. Biol. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar). The and A. Biochem. J. PubMed Scopus Google Scholar, J.P. H. J. Biochem. PubMed Scopus Google are used as of autophagy at the because of their of Gordon S. A. PubMed Scopus Google Scholar, PubMed Scopus Google Scholar). the of autophagy by is its downstream mammalian target of which of with the results in the induction of autophagy J. Biol. Full Text Full Text PDF PubMed Scopus Google Scholar, T. Ohsumi Y. J. Biol. 1998; Full Text Full Text PDF PubMed Scopus Google Scholar, B. Berger Z. Vacher C. O'Kane C.J. Rubinsztein D.C. Mol. Genet. 15: PubMed Scopus Google Scholar). were with or to or with to To the autophagic cells were with the and autophagic flux in and autophagic flux in (Fig. in a of accumulation in cells with and (Fig. with the other increased autophagy in at the level of formation (Fig. that formation the for because a of cells autophagy as by lysosomal the of cells with high steady-state increased sI/R, cells displayed (Fig. of autophagic activity during that did not autophagy during increased autophagic flux at of as cells displayed steady-state accumulation of (Fig. The of interference with the activation of autophagy cellular injury of (Fig. the of the both and increased levels of with and to and during resulted in a of cellular injury. of increased injury. lysosomal did not affect cell for to as by (Fig. However, lysosomal significantly increased following sI/R, that lysosomal not pro-apoptotic functions during in the of cell cells with were significantly against injury, that autophagy a during injury. Beclin1 from Cell Death and results autophagy as a protective to I/R injury. However, the employed are known to to autophagy C. J. Biochem. PubMed Scopus Google Scholar, J. C. G. J.C. J. 15: PubMed Scopus Google Scholar, L. Fletcher G.C. Tolkovsky A.M. Mol. Cell. PubMed Scopus Google Scholar). We to by specific in the autophagic Beclin1, which is in HL-1 cells (Fig. is a necessary in formation and is to in the of lysosomal X.H. S. M. K. B. H. Levine B. Nature. PubMed Scopus Google Scholar, A. Y. Ohsumi Y. Yoshimori T. 2001; PubMed Scopus Google Scholar). We the of of Beclin1 cellular injury. to the protective of cells that been with Beclin1 were significantly against (Fig. The interaction between Beclin1 and the PI3K, is a for the induction of autophagy A. Y. Ohsumi Y. Yoshimori T. 2001; PubMed Scopus Google Scholar), the generation of phosphatidylinositol which functions as a to autophagy A. E. J. Biol. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar). However, the presence and of did not as a of injury with the fluorescent not To whether by Beclin1 with increased autophagic quantified in cells Beclin1 following of GFP-LC3 cells a in autophagic flux sI/R, as the of cells with steady-state accumulation of decreased (Fig. We reduced Beclin1 expression the that for as an expression We found that of expression were necessary in to a knockdown of Beclin1 (Fig. with Beclin1 a reduced autophagic with as (Fig. Beclin1 cellular injury (Fig. and that autophagic activity following sI/R, is a component of the of the cell. Beclin1 against a a domain that has been to with the Bcl-2 Bcl-2 and Bcl-xL X.H. Kleeman L.K. Jiang H.H. Gordon G. Goldman J.E. Berry G. Herman B. Levine B. J. Virol. 1998; 72: 8586-8596Crossref PubMed Google Scholar, S. A. R. X.H. Mizushima N. M. Levine B. Cell. 2005; Full Text Full Text PDF PubMed Scopus Google Scholar). To whether the by Beclin1 following by the Bcl-2 we of a Beclin1 which the Bcl-2 binding domain X.H. Kleeman L.K. Jiang H.H. Gordon G. Goldman J.E. Berry G. Herman B. Levine B. J. Virol. 1998; 72: 8586-8596Crossref PubMed Google (Fig. in autophagy induction S. A. R. X.H. Mizushima N. M. Levine B. Cell. 2005; Full Text Full Text PDF PubMed Scopus Google Scholar, M. T. T. A. Mizushima N. Yoshimori T. M. B. J. J. Biol. Full Text Full Text PDF PubMed Scopus Google Scholar). reduced autophagic activity during the as in a decreased of cells with steady-state accumulation of as as a of autophagic flux (Fig. of Beclin1, expression did not against injury (Fig. a for of Atg5 and by to whether the protective by Beclin1 specific to autophagy or the result of a in the of and Bcl-2 via binding of Beclin1 to Bcl-2 To we targeted Atg5, a necessary component of the autophagic machinery of Beclin1 activity N. Yamamoto A. Hatano M. Y. Y. K. Tokuhisa T. Ohsumi Y. Yoshimori T. J. Cell Biol. 2001; PubMed Scopus Google Scholar). We of the fluorescent protein Nat. 2004; PubMed Scopus Google and Atg5 or the dominant negative mutant of Atg5, A. M. Cell Death Differ. Google Scholar). is in its to which is for the autophagosomal and autophagy at the level of formation N. T. Yoshimori T. Y. T. D.J. Ohsumi M. Ohsumi Y. Nature. 1998; PubMed Scopus Google Scholar, B. H. Mizushima N. Y. J. Biol. 2005; Full Text Full Text PDF PubMed Scopus Google Scholar). flux at following the for cells and that Atg5 is not a in the autophagic to significantly reduced autophagy during (Fig. To assess the of autophagy via expression of HL-1 cells were with and or and to (Fig. with the of an autophagic expression did not affect activation. to the results of Beclin1, expression resulted in increased that autophagic activity an protective to to whether because of its we autophagy with in Beclin1 from Beclin1 expression that Beclin1 is linked to its in autophagy (Fig. we the and of the autophagic to in the cardiac HL-1 cell We demonstrate that autophagic flux is during the and at not to the as Autophagy a protective in of autophagy with or 3-MA, knockdown of Beclin1, and of the dominant negative cardiac cells to levels of not to cell following enhanced autophagy or Beclin1 reduced These results autophagy as an intracellular against injury and during autophagy in we lysosomal degradation and the accumulation of by powerful to both and in autophagic activity in cells as as in the We found that did not with autophagic high steady-state of the of the cell to AVs, because of formation or a of downstream other that the degradation of long lived the we employed is specific to is as the pathway of autophagy is by R. C. E. A.M. Mol. Biol. Cell. 2004; 15: PubMed Scopus Google and J. Biol. 2005; Full Text Full Text PDF PubMed Scopus Google Scholar). The accumulation of during is from in the induction and formation of AVs, their to and with and their degradation the 10). the formation of to autophagy during the whereas autophagic flux in cells with the the by during the formation of the Y. T. T. Y. Y. N. Mizushima N. E. Ohsumi M. T. Ohsumi Y. Nature. 2000; PubMed Scopus Google Scholar), it is that of autophagy during the to an in the formation to a degradation of However, as the autophagic that in it is that autophagy is impaired at the level of is by that Atg5 did not autophagic that the autophagic machinery downstream of induction and not a The accumulation of in a of cells a to the autophagic pathway of One mechanism lysosomal the of some of PCD, lysosomal the via of and other V. B. T. D. H. M. D. S. J.C. V. J. Biol. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar, T. K. V. J.C. B. J. Biol. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar). decreased activity of the lysosomal has been in Y. 2001; PubMed Scopus Google Scholar). However, did not a of lysosomal at the level of the or activity that autophagic flux impaired of the accumulation of during impaired to B. Rubinsztein D.C. J. Biochem. Cell Biol. 2004; 36: PubMed Scopus Google or with M.G. Colombo M.I. J. Cell 2004; PubMed Scopus Google the (Fig. 10). both and Beclin1 increased autophagic flux by the of cells with steady-state accumulation of AVs, the of cells to their in the of Beclin1 have been to a in the of lysosomal A. Y. Ohsumi Y. Yoshimori T. 2001; PubMed Scopus Google Scholar, J. J.P. Biochem. J. 2001; PubMed Scopus Google Scholar, K. T. Ohsumi Y. Mol. Biol. Cell. PubMed Scopus Google Scholar). a of the of that and of M.G. Curr. Cell Biol. 11: PubMed Scopus Google Scholar), the of with M.G. Colombo M.I. J. Cell 2004; PubMed Scopus Google Scholar, S. C. T. E. J. Cell 2004; PubMed Scopus Google Scholar). with the Y. A.M. A. 2003; PubMed Scopus Google Scholar), and it has been suggested that the of to is by M.G. Colombo M.I. J. Cell 2004; PubMed Scopus Google Scholar). We that the by and Beclin1 is linked to to and following I/R in the between Bcl-2 and and pro-apoptotic and Bcl-2 Bcl-2 and Bcl-xL are known to protect against I/R injury V. A. M. M. M. A. H. J. 2000; PubMed Scopus Google Scholar, J. K. Y. T. M. S. K. T. Y. K. K. H. 2005; PubMed Scopus Google and were protective in Bcl-2 and Bcl-xL with Beclin1 X.H. Kleeman L.K. Jiang H.H. Gordon G. Goldman J.E. Berry G. Herman B. Levine B. J. Virol. 1998; 72: 8586-8596Crossref PubMed Google Scholar). the of to the that the protective of Beclin1 is because of its of autophagy a of Bcl-2/-xL The of the interaction between Beclin1 and is Bcl-2 has been to autophagy in cells (7Saeki K. Yuo A. Okuma E. Yazaki Y. Susin S.A. Kroemer G. Takaku F. Cell Death Differ. 2000; 7: 1263-1269Crossref PubMed Scopus (172) Google Scholar), whereas of Bcl-2 or Bcl-xL increased autophagic cell death in (9Shimizu S. Kanaseki T. Mizushima N. Mizuta T. Arakawa-Kobayashi S. Thompson C.B. Tsujimoto Y. Nat. Cell Biol. 2004; 6: 1221-1228Crossref PubMed Scopus (1192) Google Scholar). Bcl-2 to the presence of steady-state during in cells S. A. R. X.H. Mizushima N. M. Levine B. Cell. 2005; Full Text Full Text PDF PubMed Scopus Google Scholar). of Beclin1 Bcl-2 binding domain has been to formation and autophagic cell death S. A. R. X.H. Mizushima N. M. Levine B. Cell. 2005; Full Text Full Text PDF PubMed Scopus Google Scholar). However, results lysosomal to autophagic flux that expression of decreased autophagy during and did not against with Beclin1 interaction with the PI3K, as decreased and at of not expression of Bcl-2 or Bcl-xL the autophagic not significantly against injury. is in with the that Bcl-2 Bcl-2 the formation of as as degradation of long lived S. A. R. X.H. Mizushima N. M. Levine B. Cell. 2005; Full Text Full Text PDF PubMed Scopus Google Scholar). However, the between Bcl-2 and Beclin1 as Bcl-2 R. S. C. J. N. S. A. 2000; PubMed Scopus Google Scholar), whereas autophagy high M. J. Biol. Full Text PDF PubMed Google Scholar). to the between Bcl-2 of autophagy its interaction with Beclin1 of The of autophagy that an interaction between Beclin1 and Bcl-2/-xL is for autophagic for the of of both Bcl-2/-xL and increased expression of both Bcl-2 and Beclin1 is with during L. H. M. G. Matsui Y. J. S. A. 2005; PubMed Scopus Google Scholar, C. Y. V. D.J. 2004; PubMed Scopus Google Scholar). of by model of a as the cell death a of and to a cell the in the cells that and cell death, and cells that and were to The autophagosomal of mitochondria a feature in the autophagic to not is that cells that have a the of and pro-apoptotic mitochondria whereas a in to mitochondria the for as removal of mitochondria a cell with to and we determined that the pro-apoptotic Bcl-2 is a key mediator of I/R injury A. M. Cell Death Differ. Google Scholar). key that autophagy protective and with increased We of autophagy during I/R is to in an to the of such as and as as to mitochondria that via mode of the the a vital of autophagy is to toxic protein which are to a component of D. Google and to cell death following F. 2005; PubMed Scopus Google Scholar). the heart, cytosolic are known to M. S. Mol. Cell. Biochem. PubMed Scopus Google and in heart J. H. R. J. PubMed Scopus Google Scholar). of the which is for protein is decreased during I/R H. R. C. Davies H. 2005; 7: PubMed Scopus Google Scholar), because of by T. T. H. K. 2005; PubMed Scopus Google Scholar). whether autophagy for decreased activity in the heart. results demonstrate that autophagy is of the to I/R, and that of autophagy by in a with To the of the for the that autophagy constitutes an protective against I/R injury in heart are to whether autophagy a to cardiac I/R injury in HL-1 cells were by We Levine of for and for Yoshimori of for of for for and for of
Hamacher‐Brady et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: